Table 3:
Multivariable Analysis of Late GU and GI Toxicity
| Risk of Late GU Toxicity (3+) | Risk of Late GI Toxicity (2+) | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| OR | 95% CI | P value | OR | 95% CI | P value | |||
|
| ||||||||
| Treatment Type (vs IMRT) | ||||||||
| PBT | 0.55 | 0.15 | 1.99 | 0.55 | 2.68 | 0.80 | 8.98 | 0.11 |
| Race – (vs African American) | ||||||||
| Caucasian | 0.96 | 0.36 | 2.61 | 0.94 | 1.07 | 0.62 | 1.83 | 0.82 |
| Other/Unknown | 1.71 | 0.34 | 8.73 | 0.52 | 1.50 | 0.51 | 4.43 | 0.47 |
| NCCN Risk Group (vs Intermediate) | ||||||||
| Low | 0.66 | 0.24 | 1.80 | 0.41 | 0.81 | 0.51 | 1.27 | 0.35 |
| Age at Diagnosis (per year) | 0.95 | 0.91 | 1.01 | 0.09 | 1.02 | 0.99 | 1.05 | 0.22 |
| Baseline IPSS (per point) | 1.04 | 0.98 | 1.10 | 0.23 | - | - | - | - |
| Anti-Coagulant Use (vs none) | - | - | - | - | 1.90 | 1.19 | 3.04 | 0.008 |